Rapid, simple to use, financially accessible, and quality-assured point-of-care (POC) tests are urgently needed to address the high economic and social burden of sexually transmitted infections (STIs). This has resulted in the development of several POC tests such as lateral flow immunochromatographic (ICT) assays that enable diagnosis quickly outside of a standard laboratory. Many STIs can be asymptomatic or present with mild symptoms underlying the need for robust and widely available testing. Testing allows individuals to take appropriate measures and seek treatment, reducing the risk of long-term complications. Currently, the range of tests is limited and only a few have been thoroughly validated in clinical settings.